POSITRON CORP

Positron Corporation is a medical technology company that co-develops, manufactures, and sells PET and PET-CT imaging systems. The company delivers molecular imaging solutions to healthcare providers to improve the diagnosis and treatment of cardiovascular disease and other critical conditions. Positron combines proprietary PET and PET-CT systems with clinical and technical support, flexible financing, and a focus on operational efficiency. The company specializes in cardiac PET imaging and has a growing presence in oncology and neurology. Positron's systems are designed to enhance patient outcomes, maximize system uptime, and reduce total cost of ownership. In 2023, Positron entered an expanded business cooperation / OEM Supply and Distribution / SKD Manufacturer Agreement with Shenyang Intelligent Neuclear Medical Technology Co., a subsidiary of Neusoft Medical Systems. This agreement secured exclusive rights for the North American market to sell/distribute PET, PET-CT, and next-generation PET-CT scanners in the future. Positron maintains a primary focus on cardiac PET imaging, which is utilized in nuclear cardiology for the diagnosis and management of cardiovascular disease. The company's imaging portfolio includes its dedicated PET system and its next-generation PET-CT platform. Positron is preparing for the introduction of its Affinity™ PET-CT 4D 64-slice system.